![Sophia H. Twaddell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sophia H. Twaddell
Nessuna posizione attualmente
Storia della carriera di Sophia H. Twaddell
Precedenti posizioni note di Sophia H. Twaddell
Società | Posizione | Inizio | Fine |
---|---|---|---|
Northfield Laboratories, Inc.
![]() Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Public Communications Contact | 01/01/2003 | 10/11/2009 |
Fleishman-Hillard, Inc.
![]() Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Fleishman Hillard, Inc. is a strategic communications company. It provides public relations, public affairs and marketing communications services. The company was founded in 1946 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | 01/01/1999 | 01/01/2002 |
Prudential Vector Healthcare Group | Corporate Officer/Principal | - | - |
Formazione di Sophia H. Twaddell
Northwestern University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Public Communications Contact | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Northfield Laboratories, Inc.
![]() Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
Fleishman-Hillard, Inc.
![]() Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Fleishman Hillard, Inc. is a strategic communications company. It provides public relations, public affairs and marketing communications services. The company was founded in 1946 and is headquartered in St. Louis, MO. | Commercial Services |
Prudential Vector Healthcare Group | Finance |
- Borsa valori
- Insiders
- Sophia H. Twaddell
- Esperienza